Patents by Inventor Pål Sætrom

Pål Sætrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C/EBP Alpha Short Activating RNA Compositions and Methods of Use
    Publication number: 20240124874
    Abstract: The invention relates to saRNAs targeting a C/EBP? transcript and therapeutic compositions comprising said saRNAs. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: December 23, 2022
    Publication date: April 18, 2024
    Applicant: MiNA Therapeutics Limited
    Inventor: Pål Sætrom
  • Albumin Production and Cell Proliferation
    Publication number: 20240002854
    Abstract: The present invention provides short activating RNA molecules which up-regulate albumin production. The present invention also provides methods of up-regulating albumin production, such methods involving the use of short activating RNA molecules capable of increasing the expression of albumin. The present invention also provides the use of the short activating RNA molecules in therapy, such as treating or preventing a hyperproliferative disorder and/or a disorder characterised by hypoalbuminemia.
    Type: Application
    Filed: May 12, 2023
    Publication date: January 4, 2024
    Applicant: MiNA Therapeutics Limited
    Inventor: Pål Sætrom
  • METHODS OF INDUCING INSULIN PRODUCTION
    Publication number: 20220282256
    Abstract: The present invention provides a method of inducing insulin production in a cell by up-regulating a target gene involved in insulin production in said cell using an saRNA (short activating ribonucleic acid) which specifically targets a target antisense RNA transcript present in said cell.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 8, 2022
    Inventor: Pål Sætrom
  • Methods of inducing insulin production
    Patent number: 11365414
    Abstract: The present invention provides a method of inducing insulin production in a cell by up-regulating a target gene involved in insulin production in said cell using an saRNA (short activating ribonucleic acid) which specifically targets a target antisense RNA transcript present in said cell.
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: June 21, 2022
    Assignee: MINA THERAPEUTICS LIMITED
    Inventor: Pål Sætrom
  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20210363525
    Abstract: The invention relates to oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of making and using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: May 13, 2021
    Publication date: November 25, 2021
    Inventors: Pål Sætrom, Endre Bakken Stovner
  • COMBINATION THERAPIES COMPRISING C/EBP ALPHA SARNA
    Publication number: 20210254069
    Abstract: The invention relates to a combination therapy comprising an saRNA targeting C/EBP? and at least one additional active agent. Methods of using the combination therapy are also provided.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 19, 2021
    Inventors: Helen L Lightfoot, Vikash Reebye, Pål Sætrom, David Blakey, Choon Ping Tan
  • C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20210187007
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: December 9, 2020
    Publication date: June 24, 2021
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Saetrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • C/EBP alpha saRNA compositions and methods of use
    Patent number: 10912790
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: February 9, 2021
    Assignee: MiNA THERAPEUTICS LIMITED
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Sætrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200376020
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: December 3, 2020
    Applicant: MiNA THERAPEUTICS LIMITED
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Sætrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • METHODS OF INDUCING INSULIN PRODUCTION
    Publication number: 20200362352
    Abstract: The present invention provides a method of inducing insulin production in a cell by up-regulating a target gene involved in insulin production in said cell using an saRNA (short activating ribonucleic acid) which specifically targets a target antisense RNA transcript present in said cell.
    Type: Application
    Filed: August 11, 2020
    Publication date: November 19, 2020
    Inventor: Pål Sætrom
  • C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200318114
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: March 10, 2020
    Publication date: October 8, 2020
    Inventor: Pål Sætrom
  • Methods of inducing insulin production
    Patent number: 10774331
    Abstract: The present invention provides a method of inducing insulin production in a cell by up-regulating a target gene involved in insulin production in said cell using an saRNA (short activating ribonucleic acid) which specifically targets a target antisense RNA transcript present in said cell.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: September 15, 2020
    Assignee: MiNA THERAPEUTICS LIMITED
    Inventor: Pål Sætrom
  • ALBUMIN PRODUCTION AND CELL PROLIFERATION
    Publication number: 20200283771
    Abstract: The present invention provides short activating RNA molecules which up-regulate albumin production. The present invention also provides methods of up-regulating albumin production, such methods involving the use of short activating RNA molecules capable of increasing the expression of albumin. The present invention also provides the use of the short activating RNA molecules in therapy, such as treating or preventing a hyperproliferative disorder and/or a disorder characterised by hypoalbuminemia.
    Type: Application
    Filed: May 22, 2020
    Publication date: September 10, 2020
    Inventor: Pål Sætrom
  • Albumin production and cell proliferation
    Patent number: 10704044
    Abstract: The present invention provides short activating RNA molecules which up-regulate albumin production. The present invention also provides methods of up-regulating albumin production, such methods involving the use of short activating RNA molecules capable of increasing the expression of albumin. The present invention also provides the use of the short activating RNA molecules in therapy, such as treating or preventing a hyperproliferative disorder and/or a disorder characterised by hypoalbuminemia.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: July 7, 2020
    Assignee: MiNA THERAPEUTICS LIMITED
    Inventor: Pål Sætrom
  • C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20190249176
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: December 19, 2018
    Publication date: August 15, 2019
    Inventor: PÅL SÆTROM
  • C/EBP? short activating RNA compositions and methods of use
    Patent number: 10202601
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: February 12, 2019
    Assignee: MiNA THERAPEUTICS LIMITED
    Inventor: Pål Sætrom
  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20180305689
    Abstract: The invention relates to oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: October 25, 2018
    Inventors: Pål Sætrom, Endre Bakken Stovner
  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20180258429
    Abstract: The invention relates to a saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Pål Sætrom, Endre Bakken Stovner
  • ALBUMIN PRODUCTION AND CELL PROLIFERATION
    Publication number: 20180201932
    Abstract: The present invention provides short activating RNA molecules which up-regulate albumin production. The present invention also provides methods of up-regulating albumin production, such methods involving the use of short activating RNA molecules capable of increasing the expression of albumin. The present invention also provides the use of the short activating RNA molecules in therapy, such as treating or preventing a hyperproliferative disorder and/or a disorder characterised by hypoalbuminemia.
    Type: Application
    Filed: March 8, 2018
    Publication date: July 19, 2018
    Inventor: Pål Sætrom
  • METHODS OF INDUCING INSULIN PRODUCTION
    Publication number: 20180112222
    Abstract: The present invention provides a method of inducing insulin production in a cell by up-regulating a target gene involved in insulin production in said cell using an saRNA (short activating ribonucleic acid) which specifically targets a target antisense RNA transcript present in said cell.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 26, 2018
    Inventor: Pål Sætrom